Due to a production error, an author name was incorrectly written as “Y. Maurice II Morillon.” The correct name is “Y. Maurice Morillon II.” The publisher apologizes for this mistake. The original article has been updated.
Summary
Keywords
humanized mouse, NSG-β2m−/−, bintrafusp alfa, immunotherapy, TGF-β
Citation
Frontiers Production Office (2020) Erratum: The Use of a Humanized NSG-β2m−/− Model for Investigation of Immune and Anti-tumor Effects Mediated by the Bifunctional Immunotherapeutic Bintrafusp Alfa. Front. Oncol. 10:1548. doi: 10.3389/fonc.2020.01548
Received
17 July 2020
Accepted
20 July 2020
Published
24 July 2020
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
10 - 2020
Updates
Copyright
© 2020 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office production.office@frontiersin.org
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.